This randomized clinical trial evaluates the association of pathologic complete response with event-free survival and distant recurrence–free survival in subpopulations of women with high-risk operable breast cancer treated with standard therapy or one of several novel agents.
Up-to-date medical news aggregated from trusted medical associations, journals, physicians and news outlets from around the world.